Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 549

1.

Novel inverse planning optimization algorithm for robotic radiosurgery: First clinical implementation and dosimetric evaluation.

Zeverino M, Marguet M, Zulliger C, Durham A, Jumeau R, Herrera F, Schiappacasse L, Bourhis J, Bochud FO, Moeckli R.

Phys Med. 2019 Aug;64:230-237. doi: 10.1016/j.ejmp.2019.07.020. Epub 2019 Aug 1.

PMID:
31515024
2.

FLASH radiotherapy International Workshop.

Vozenin MC, Baumann M, Coppes RP, Bourhis J.

Radiother Oncol. 2019 Aug 21. pii: S0167-8140(19)33013-0. doi: 10.1016/j.radonc.2019.07.020. [Epub ahead of print] No abstract available.

PMID:
31445836
3.

Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Halaburda K, Labopin M, Mailhol A, Socié G, Craddock C, Aljurf M, Beelen D, Cornelissen JJ, Bourhis JH, Labussière-Wallet H, Blaise D, Gedde-Dahl T, Gilleece M, Yakoub-Agha I, Mufti G, Esteve J, Mohty M, Nagler A.

Haematologica. 2019 Aug 22. pii: haematol.2019.222810. doi: 10.3324/haematol.2019.222810. [Epub ahead of print]

4.

Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy.

Ozsahin M, Slotman BJ, Bourhis J.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):233-234. doi: 10.1016/j.ijrobp.2019.05.037. No abstract available.

PMID:
31422814
5.

[Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].

Beddok A, Vela A, Calugaru V, Tessonnier T, Kubes J, Dutheil P, Gérard A, Vidal M, Goudjil F, Florescu C, Kammerer E, Bénézery K, Hérault J, Bourhis J, Thariat J; Gortec et de trois centres français.

Cancer Radiother. 2019 Sep;23(5):439-448. doi: 10.1016/j.canrad.2019.05.015. Epub 2019 Jul 26. French.

PMID:
31358445
6.

Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.

Dauzier E, Lacas B, Blanchard P, Le QT, Simon C, Wolf G, Janot F, Horiuchi M, Tobias JS, Moon J, Simes J, Deshmane V, Mazeron JJ, Mehta S, Zaktonik B, Tamura M, Moyal E, Licitra L, Fortpied C, Haffty BG, Ghi MG, Gregoire V, Harris J, Bourhis J, Aupérin A, Pignon JP; MACH-NC Collaborative Group.

Oral Oncol. 2019 Aug;95:106-114. doi: 10.1016/j.oraloncology.2019.06.001. Epub 2019 Jun 15.

PMID:
31345376
7.

Treatment of a first patient with FLASH-radiotherapy.

Bourhis J, Sozzi WJ, Jorge PG, Gaide O, Bailat C, Duclos F, Patin D, Ozsahin M, Bochud F, Germond JF, Moeckli R, Vozenin MC.

Radiother Oncol. 2019 Jul 11. pii: S0167-8140(19)32959-7. doi: 10.1016/j.radonc.2019.06.019. [Epub ahead of print]

PMID:
31303340
8.

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI.

Nagler A, Labopin M, Dholaria B, Niittyvuopio R, Maertens J, Poiré X, Cornelissen J, Reményi P, Bourhis JH, Beguin Y, Malladi R, Kerre T, Schroyens W, Savani BN, Mohty M.

Blood Adv. 2019 Jul 9;3(13):1950-1960. doi: 10.1182/bloodadvances.2019000030.

9.

Clinical translation of FLASH radiotherapy: Why and how?

Bourhis J, Montay-Gruel P, Gonçalves Jorge P, Bailat C, Petit B, Ollivier J, Jeanneret-Sozzi W, Ozsahin M, Bochud F, Moeckli R, Germond JF, Vozenin MC.

Radiother Oncol. 2019 Jun 25. pii: S0167-8140(19)30360-3. doi: 10.1016/j.radonc.2019.04.008. [Epub ahead of print]

PMID:
31253466
10.

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice.

Szturz P, Cristina V, Herrera Gómez RG, Bourhis J, Simon C, Vermorken JB.

Front Oncol. 2019 Jun 11;9:464. doi: 10.3389/fonc.2019.00464. eCollection 2019. Review.

11.

Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.

De Bari B, Franzetti-Pellanda A, Saidi A, Biggiogero M, Hahnloser D, Montemurro M, Bourhis J, Zeverino M, Ozsahin M.

J Cancer Res Clin Oncol. 2019 Aug;145(8):2167. doi: 10.1007/s00432-019-02939-7.

PMID:
31201485
12.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators.

JAMA Oncol. 2019 Jun 13. doi: 10.1001/jamaoncol.2019.1146. [Epub ahead of print]

PMID:
31194247
13.

Dosimetric and preparation procedures for irradiating biological models with pulsed electron beam at ultra-high dose-rate.

Jorge PG, Jaccard M, Petersson K, Gondré M, Durán MT, Desorgher L, Germond JF, Liger P, Vozenin MC, Bourhis J, Bochud F, Moeckli R, Bailat C.

Radiother Oncol. 2019 Jun 4. pii: S0167-8140(19)30403-7. doi: 10.1016/j.radonc.2019.05.004. [Epub ahead of print]

PMID:
31174897
14.

[Management of refractory ventricular tachycardia using stereotactic body radiotherapy].

Jumeau R, Bourhis J, Ozsahin M, Vallet V, Zeverino M, Moeckli R, Kinj R, Vozenin MC, Schwitter J, Herrera-Siklody C, Pascale P, Pruvot É.

Rev Med Suisse. 2019 May 22;15(652):1082-1086. French.

PMID:
31116523
15.

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.

Baron F, Efficace F, Cannella L, Willemze R, Vignetti M, Muus P, Marie JP, Ferrero D, Fazi P, La Sala E, Bourhis JH, Fabbiano F, Bosi A, Sborgia M, Martinelli G, Wittnebel S, Trisolini S, Petti MC, Halkes CJM, van der Velden WJFM, de Witte T, Amadori S, Zittoun RA, Suciu S.

Haematologica. 2019 May 16. pii: haematol.2019.221333. doi: 10.3324/haematol.2019.221333. [Epub ahead of print]

16.

Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.

Montay-Gruel P, Acharya MM, Petersson K, Alikhani L, Yakkala C, Allen BD, Ollivier J, Petit B, Jorge PG, Syage AR, Nguyen TA, Baddour AAD, Lu C, Singh P, Moeckli R, Bochud F, Germond JF, Froidevaux P, Bailat C, Bourhis J, Vozenin MC, Limoli CL.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):10943-10951. doi: 10.1073/pnas.1901777116. Epub 2019 May 16.

17.

Isodose 20 Gy found as a threshold dose for radiation recall dermatitis.

Scher N, Vozenin MC, Bouchaab H, Ozsahin M, Bourhis J.

Clin Transl Radiat Oncol. 2019 Apr 11;17:14-16. doi: 10.1016/j.ctro.2019.03.003. eCollection 2019 Jul.

18.

Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.

Biau J, Lapeyre M, Troussier I, Budach W, Giralt J, Grau C, Kazmierska J, Langendijk JA, Ozsahin M, O'Sullivan B, Bourhis J, Grégoire V.

Radiother Oncol. 2019 May;134:1-9. doi: 10.1016/j.radonc.2019.01.018. Epub 2019 Jan 30.

PMID:
31005201
19.

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.

Schmidt-Hieber M, Tridello G, Ljungman P, Mikulska M, Knelange N, Blaise D, Socié G, Volin L, Blijlevens N, Fegueux N, Yakoub-Agha I, Forcade E, Maertens J, Chevallier P, Passweg J, Cornelissen J, Russell N, Craddock C, Bourhis JH, Marchand T, Reményi P, Cahn JY, Michallet M, Montoto S, Kröger N, Glaß B, Styczynski J.

Ann Hematol. 2019 Jul;98(7):1755-1763. doi: 10.1007/s00277-019-03669-z. Epub 2019 Apr 16.

PMID:
30993417
20.

Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation.

Gagelmann N, Eikema DJ, de Wreede LC, Koster L, Wolschke C, Arnold R, Kanz L, McQuaker G, Marchand T, Socié G, Bourhis JH, Mohty M, Cornelissen JJ, Chevallier P, Bernasconi P, Stelljes M, Rohrlich PS, Fanin R, Finke J, Maertens J, Blaise D, Itälä-Remes M, Labussière-Wallet H, Robin M, McLornan D, Chalandon Y, Yakoub-Agha I, Kröger N; CMWP of the European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2019 Jun;25(6):e204-e208. doi: 10.1016/j.bbmt.2019.03.024. Epub 2019 Mar 28.

PMID:
30930192
21.

Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia.

Canaani J, Labopin M, Itälä-Remes M, Blaise D, Socié G, Forcade E, Maertens J, Wu D, Malladi R, Cornelissen JJ, Huynh A, Bourhis JH, Esteve J, Mohty M, Nagler A.

Leukemia. 2019 Aug;33(8):1944-1952. doi: 10.1038/s41375-019-0439-3. Epub 2019 Mar 7.

PMID:
30846862
22.

Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.

De Bari B, Franzetti-Pellanda A, Saidi A, Biggiogero M, Hahnloser D, Montemurro M, Bourhis J, Zeverino M, Ozsahin M.

J Cancer Res Clin Oncol. 2019 Apr;145(4):1075-1084. doi: 10.1007/s00432-019-02881-8. Epub 2019 Mar 4. Erratum in: J Cancer Res Clin Oncol. 2019 Jun 14;:.

23.

In air and in vivo measurement of the leaf open time in tomotherapy using the on-board detector pulse-by-pulse data.

Schopfer M, Bochud FO, Bourhis J, Moeckli R.

Med Phys. 2019 May;46(5):1963-1971. doi: 10.1002/mp.13459. Epub 2019 Mar 22.

PMID:
30810233
24.

Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.

Bourgier C, Auperin A, Rivera S, Boisselier P, Petit B, Lang P, Lassau N, Taourel P, Tetreau R, Azria D, Bourhis J, Deutsch E, Vozenin MC.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):365-373. doi: 10.1016/j.ijrobp.2019.02.024. Epub 2019 Feb 15.

PMID:
30776452
25.

Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC).

Fayard A, Daguenet E, Blaise D, Chevallier P, Labussière H, Berceanu A, Yakoub-Agha I, Socié G, Charbonnier A, Suarez F, Huynh A, Mercier M, Bulabois CE, Lioure B, Chantepie S, Beguin Y, Bourhis JH, Malfuson JV, Clément L, Peffault de la Tour R, Cornillon J.

Bone Marrow Transplant. 2019 Feb 15. doi: 10.1038/s41409-019-0475-7. [Epub ahead of print]

PMID:
30770870
26.

Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells.

Marinelli L, Martin-Gallausiaux C, Bourhis JM, Béguet-Crespel F, Blottière HM, Lapaque N.

Sci Rep. 2019 Jan 24;9(1):643. doi: 10.1038/s41598-018-37019-2.

27.

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis.

Robin M, Chevret S, Koster L, Wolschke C, Yakoub-Agha I, Bourhis JH, Chevallier P, Cornelissen JJ, Reményi P, Maertens J, Poiré X, Craddock C, Socié G, Itälä-Remes M, Schouten HC, Marchand T, Passweg J, Blaise D, Damaj G, Ozkurt ZN, Zuckerman T, Cluzeau T, Labussière-Wallet H, Cammenga J, McLornan D, Chalandon Y, Kröger N.

Haematologica. 2019 Jun;104(6):1230-1236. doi: 10.3324/haematol.2018.201400. Epub 2019 Jan 17.

28.

[Chemoradiation for oesophageal cancer: A critical review of the literature].

Blais E, Vendrely V, Sargos P, Créhange G, Huguet F, Maingon P, Simon JM, Bourdais R, Ozsahin M, Bourhis J, Clément-Colmou K, Belghith B, Proudhom Briois MA, Gilliot O, Dujols JP, Peyras A, Dupin C, Riet FG, Canova CH, Huertas A, Troussier I.

Cancer Radiother. 2019 Feb;23(1):62-72. doi: 10.1016/j.canrad.2018.05.003. Epub 2019 Jan 11. Review. French.

PMID:
30639379
29.

Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation.

Lee CJ, Labopin M, Beelen D, Finke J, Blaise D, Ganser A, Itälä-Remes M, Chevallier P, Labussière-Wallet H, Maertens J, Yakoub-Agha I, Bourhis JH, Mailhol A, Mohty M, Savani BN, Nagler A.

Am J Hematol. 2019 Apr;94(4):431-438. doi: 10.1002/ajh.25395. Epub 2019 Jan 10.

PMID:
30597620
30.

Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC.

Le Bourgeois A, Labopin M, Leclerc M, de Latour RP, Bourhis JH, Ceballos P, Orvain C, Wallet HL, Bilger K, Blaise D, Rubio MT, Guillaume T, Mohty M, Chevallier P; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Oncotarget. 2018 Nov 27;9(93):36603-36612. doi: 10.18632/oncotarget.26391. eCollection 2018 Nov 27.

31.

Establishment and Characterization of a Reliable Xenograft Model of Hodgkin Lymphoma Suitable for the Study of Tumor Origin and the Design of New Therapies.

M'kacher R, Frenzel M, Al Jawhari M, Junker S, Cuceu C, Morat L, Bauchet AL, Stimmer L, Lenain A, Dechamps N, Hempel WM, Pottier G, Heidingsfelder L, Laplagne E, Borie C, Oudrhiri N, Jouni D, Bennaceur-Griscelli A, Colicchio B, Dieterlen A, Girinsky T, Boisgard R, Bourhis J, Bosq J, Mehrling T, Jeandidier E, Carde P.

Cancers (Basel). 2018 Oct 31;10(11). pii: E414. doi: 10.3390/cancers10110414.

32.

Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.

De Bari B, Breuneval T, Zeverino M, Godin S, Deantonio L, Geldhof C, Bourhis J, Schaefer N, Moeckli R, Prior J, Ozsahin M.

PLoS One. 2018 Oct 10;13(10):e0204013. doi: 10.1371/journal.pone.0204013. eCollection 2018.

33.

Adaptive radiotherapy for head and neck cancer.

Castelli J, Simon A, Lafond C, Perichon N, Rigaud B, Chajon E, De Bari B, Ozsahin M, Bourhis J, de Crevoisier R.

Acta Oncol. 2018 Oct;57(10):1284-1292. doi: 10.1080/0284186X.2018.1505053. Epub 2018 Oct 5. Review.

PMID:
30289291
34.

50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.

Herrera FG, Valerio M, Berthold D, Tawadros T, Meuwly JY, Vallet V, Baumgartner P, Thierry AC, De Bari B, Jichlinski P, Kandalaft L, Coukos G, Harari A, Bourhis J.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):320-334. doi: 10.1016/j.ijrobp.2018.09.023. Epub 2018 Sep 27.

35.

Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC.

Caulier A, Drumez E, Gauthier J, Robin M, Blaise D, Beguin Y, Michallet M, Chevallier P, Bay JO, Vigouroux S, Desbrosses Y, Cornillon J, Nguyen S, Dauriac C, de Latour RP, Lioure B, Rohrlich PS, Carré M, Bourhis JH, Huynh A, Suarez F, Garnier F, Duhamel A, Yakoub-Agha I.

Curr Res Transl Med. 2019 Feb;67(1):8-15. doi: 10.1016/j.retram.2018.08.003. Epub 2018 Sep 8.

36.

Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers.

Biau J, Dunet V, Lapeyre M, Simon C, Ozsahin M, Grégoire V, Bourhis J.

Radiother Oncol. 2019 Feb;131:192-201. doi: 10.1016/j.radonc.2018.08.020. Epub 2018 Sep 8.

PMID:
30206021
37.

X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice.

Montay-Gruel P, Bouchet A, Jaccard M, Patin D, Serduc R, Aim W, Petersson K, Petit B, Bailat C, Bourhis J, Bräuer-Krisch E, Vozenin MC.

Radiother Oncol. 2018 Dec;129(3):582-588. doi: 10.1016/j.radonc.2018.08.016. Epub 2018 Aug 31.

PMID:
30177374
38.

PET-based prognostic survival model after radiotherapy for head and neck cancer.

Castelli J, Depeursinge A, Devillers A, Campillo-Gimenez B, Dicente Y, Prior JO, Chajon E, Jegoux F, Sire C, Acosta O, Gherga E, Sun X, De Bari B, Bourhis J, de Crevoisier R.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):638-649. doi: 10.1007/s00259-018-4134-9. Epub 2018 Aug 21.

PMID:
30132054
39.

Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy.

Boivin G, Kalambaden P, Faget J, Rusakiewicz S, Montay-Gruel P, Meylan E, Bourhis J, Lesec G, Vozenin MC.

Front Oncol. 2018 Jul 9;8:256. doi: 10.3389/fonc.2018.00256. eCollection 2018.

40.

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.

Geoffrois L, Martin L, De Raucourt D, Sun XS, Tao Y, Maingon P, Buffet J, Pointreau Y, Sire C, Tuchais C, Babin E, Coutte A, Rolland F, Kaminsky MC, Alfonsi M, Lapeyre M, Saliou M, Lafond C, Jadaud E, Gery B, Zawadi A, Tourani JM, Khoury C, Henry AR, Hasbini A, Guichard F, Borel C, Meert N, Guillet P, Calais MH, Garaud P, Bourhis J.

J Clin Oncol. 2018 Jul 17:JCO2017762591. doi: 10.1200/JCO.2017.76.2591. [Epub ahead of print]

PMID:
30016178
41.

High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.

Avivi I, Arcaini L, Ferretti VV, Boumendil A, Finel H, Milone G, Zaja F, Liliana D, Musso M, Didier B, Bachy E, Wattad M, Nicolas-Virelizier E, Gramatzki M, Bourhis JH, Caillot D, Haenel A, Held G, Thieblemont C, Jindra P, Pohlreich D, Guilhot F, Kroschinsky F, Wahlin B, Scheid C, Ifrah N, Berthou C, Dreger P, Montoto S, Conconi A.

Br J Haematol. 2018 Sep;182(6):807-815. doi: 10.1111/bjh.15454. Epub 2018 Jul 9.

PMID:
29984825
42.

Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation.

Gilleece MH, Labopin M, Yakoub-Agha I, Volin L, Socié G, Ljungman P, Huynh A, Deconinck E, Wu D, Bourhis JH, Cahn JY, Polge E, Mohty M, Savani BN, Nagler A.

Am J Hematol. 2018 Sep;93(9):1142-1152. doi: 10.1002/ajh.25211. Epub 2018 Aug 15.

43.

Response to Spartalis et al.

Jumeau R, Ozsahin M, Moeckli R, Pruvot E, Bourhis J.

Radiother Oncol. 2018 Aug;128(2):388. doi: 10.1016/j.radonc.2018.06.015. Epub 2018 Jun 28. No abstract available.

PMID:
29961582
44.

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.

Tao Y, Auperin A, Sire C, Martin L, Khoury C, Maingon P, Bardet E, Kaminsky MC, Lapeyre M, Chatellier T, Alfonsi M, Pointreau Y, Jadaud E, Géry B, Zawadi A, Tourani JM, Laguerre B, Coutte A, Racadot S, Hasbini A, Malaurie E, Borel C, Meert N, Cornely A, Ollivier N, Casiraghi O, Sun XS, Bourhis J.

J Clin Oncol. 2018 Jun 7:JCO2017762518. doi: 10.1200/JCO.2017.76.2518. [Epub ahead of print]

PMID:
29878867
45.

The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients.

Vozenin MC, De Fornel P, Petersson K, Favaudon V, Jaccard M, Germond JF, Petit B, Burki M, Ferrand G, Patin D, Bouchaab H, Ozsahin M, Bochud F, Bailat C, Devauchelle P, Bourhis J.

Clin Cancer Res. 2019 Jan 1;25(1):35-42. doi: 10.1158/1078-0432.CCR-17-3375. Epub 2018 Jun 6.

46.

Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?

Robinson TM, Fuchs EJ, Zhang MJ, St Martin A, Labopin M, Keesler DA, Blaise D, Bashey A, Bourhis JH, Ciceri F, Ciurea SO, Devine SM, Mohty M, McCurdy SR, Milpied N, McNiece IK, Rocha V, Romee R, Socie G, Yakoub-Agha I, Soiffer RJ, Eapen M, Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research.

Blood Adv. 2018 Jun 12;2(11):1180-1186. doi: 10.1182/bloodadvances.2018018291.

47.

Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.

Tao Y, Faivre L, Laprie A, Boisselier P, Ferron C, Jung GM, Racadot S, Gery B, Even C, Breuskin I, Bourhis J, Janot F.

Radiother Oncol. 2018 Sep;128(3):467-471. doi: 10.1016/j.radonc.2018.05.005. Epub 2018 May 18.

PMID:
29784451
48.

Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation.

Jumeau R, Ozsahin M, Schwitter J, Vallet V, Duclos F, Zeverino M, Moeckli R, Pruvot E, Bourhis J.

Radiother Oncol. 2018 Aug;128(2):189-191. doi: 10.1016/j.radonc.2018.04.025. Epub 2018 May 9.

PMID:
29753550
49.

Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F, Blaise D, Arcese W, Sociè G, Bourhis JH, Van Lint MT, Bruno B, Huynh A, Santarone S, Deconinck E, Mohty M, Nagler A.

Haematologica. 2018 Aug;103(8):1317-1328. doi: 10.3324/haematol.2018.189258. Epub 2018 May 10.

50.

(18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.

Scher N, Castelli J, Depeursinge A, Bourhis J, Prior JO, Herrera FG, Ozsahin M.

Cancer Radiother. 2018 May;22(3):229-235. doi: 10.1016/j.canrad.2017.10.003. Epub 2018 Apr 9.

PMID:
29650390

Supplemental Content

Loading ...
Support Center